Details pending.

Position: Long

12m Target: $225.00

Catalyst: Clear evidence over the next 2-3 quarters that GTF-related aircraft-on-ground counts are peaking, combined with stronger free cash flow conversion and defense margin recovery in earnings/guidance updates.

Primary Risk: A renewed expansion of the GTF inspection/remediation scope or slower-than-expected turnaround times, which would push out cash recovery, damage customer confidence, and offset strength in the rest of the portfolio.

Exit Trigger: We would exit if management indicates a material increase in GTF fleet impact or cash costs beyond current expectations, or if consolidated free cash flow timing slips enough to break the thesis that 2025-2026 earnings and cash are inflecting upward.

• ?:
• ?:
• ?:
• ?:
• ?:

The clearest catalyst in the authoritative record is simple: RTX exited 2025 with materially stronger earnings than the 2024 revenue base implies. On an annual basis, 2024 revenue was $80.74B, while the deterministic ratio set shows revenue growth of +17.1% YoY, net income growth of +41.0% YoY, and diluted EPS growth of +39.7% YoY. Reported 2025 annual operating income reached $9.30B, annual net income reached $6.73B, and diluted EPS reached $4.96. That combination matters because the progression through the year was sequentially constructive rather than flat: operating income moved from $2.04B in 2025 Q1 to $2.15B in Q2 and then $2.52B in Q3, while quarterly diluted EPS moved from $1.14 to $1.22 to $1.41 over the same periods.

For a catalyst map, the practical implication is that each new quarterly print has the potential to validate a higher earnings run-rate if management can sustain or improve on those 2025 exit rates. The institutional survey adds a second layer of support: it shows estimated EPS of $6.80 for 2026 and $7.50 for 2027, versus $6.28 for 2025, alongside revenue per share moving from $66.01 in 2025 to an estimated $69.85 in 2026 and $74.65 in 2027. Relative to named peers in the survey, including Boeing Co and General Electric, that sets up a classic execution catalyst: if RTX continues to convert top-line growth into faster EPS growth, investors may reward the stock for earnings quality and consistency rather than only for sector sentiment.

Just as important, profitability is not being achieved through a collapse in spending. RTX still invested $2.81B in R&D during 2025, equal to 3.2% of revenue, while SG&A was 6.9% of revenue. That indicates the earnings improvement happened with substantial operating investment still in place. If future reports show that RTX can hold operating margin at 10.5% or better while continuing to fund product development, the market may view 2025 less as a peak year and more as a new baseline. That is the highest-confidence catalyst visible.

A second important catalyst is financial flexibility. RTX ended 2025 with cash and equivalents of $7.43B, up from $5.58B at 2024 year-end. Operating cash flow for 2025 was $10.567B and free cash flow was $7.94B, implying an FCF margin of 9.0%. At the same time, capital spending remained meaningful at $2.63B for the full year, very close to the $2.62B recorded in 2024. In other words, RTX improved its liquidity position without obviously starving the business of investment. That matters because investors often reward aerospace and defense companies when higher earnings convert cleanly into cash, especially when those companies still maintain research and capital intensity.

The balance sheet also moved in a constructive direction during 2025. Total assets increased from $162.86B at 2024 year-end to $171.08B at 2025 year-end, while shareholders’ equity rose from $60.16B to $65.25B. Total liabilities increased more modestly, from $100.90B to $103.94B, leaving total liabilities to equity at 1.59 and debt to equity at 0.63 in the deterministic ratio set. Current assets rose to $60.33B versus current liabilities of $58.78B, producing a current ratio of 1.03. That is not a huge liquidity cushion, but it does indicate RTX remained on the right side of short-term coverage while improving cash balances.

Why is this a catalyst rather than just a balance-sheet observation? Because stronger cash and a firmer equity base create optionality. RTX can continue funding R&D, which was $2.81B in 2025, maintain CapEx, and still preserve room for capital allocation decisions that the market could interpret favorably. Relative to peers named in the institutional survey such as Boeing Co and General Electric, a company showing both earnings acceleration and rising year-end cash can attract investors looking for a combination of defense-like stability and industrial execution. If management demonstrates that 2025 cash generation is repeatable, the stock’s quality narrative could strengthen further.

RTX’s valuation setup is itself a catalyst because it is balanced rather than obviously distressed or euphoric on the independent survey framework. The stock price was $198.16 as of Mar. 22, 2026, while the institutional analyst target range for the next three to five years is $185.00 to $250.00. That places the shares inside the stated range and closer to the midpoint than to either extreme. In practical terms, that means the next rerating likely depends on evidence that 2025 was not just a rebound year but the start of a higher earnings and cash-flow path. The deterministic ratios support that possibility: operating margin was 10.5%, net margin was 7.6%, return on equity was 10.3%, and return on invested capital was 7.7%.

There is also a tension investors will watch closely. On one hand, RTX has a Safety Rank of 2, Timeliness Rank of 2, Financial Strength of A, Price Stability of 90, and beta of 1.00 in the institutional data, all of which are consistent with a relatively solid large-cap profile. On the other hand, the shares trade at a 40.0x P/E, which means good but not exceptional results may already be partially reflected in the price. That creates a classic catalyst threshold: if quarterly results show the company tracking toward the survey’s EPS estimates of $6.80 for 2026 and $7.50 for 2027, investors may become more comfortable paying for durability. If results miss that path, multiple compression becomes a realistic counterforce.

Relative to listed peers such as Boeing Co and General Electric, RTX’s investment case in this pane is distinguished by a combination of audited 2025 earnings improvement and forecasted per-share growth in 2026 and 2027. Dividend estimates also rise from $2.67 in 2025 to $2.90 in 2026 and $3.05 in 2027, while book value per share is expected to increase from $48.61 in 2025 to $50.95 in 2026 and $53.40 in 2027. Those are not standalone catalysts by themselves, but together they define the pathway to the upper end of the target range: maintain earnings momentum, convert it to cash, and show that per-share value keeps compounding.

The institutional survey places RTX in the Aerospace/Defense industry and assigns the industry a rank of 43 of 94. That framing matters because it suggests RTX is not operating in a top-ranked momentum group or a deeply out-of-favor one based on the supplied cross-validation data. In that kind of middle-ranked industry backdrop, stock-specific catalysts tend to matter more than broad sector beta. Named peers in the survey include Boeing Co and General Electric, which makes RTX’s relative appeal in this pane depend on measurable consistency: audited profitability, cash generation, and per-share growth expectations. The company’s own cross-validation scores are constructive, with Safety Rank 2, Timeliness Rank 2, Financial Strength A, and Earnings Predictability 55.

From a catalyst perspective, the key peer comparison is qualitative but still useful. Boeing Co and General Electric are specific competitors or comparison names investors are likely to use when judging whether RTX deserves premium treatment. What the supplied record does show is that RTX already combines scale and improving returns: 2025 annual net income was $6.73B, operating cash flow was $10.567B, free cash flow was $7.94B, and shareholders’ equity finished the year at $65.25B. Those figures give RTX a stronger case for resilience than a story based only on top-line growth.

The historical context in the survey also supports a compounding thesis. Four-year CAGR figures show EPS growth of +10.1%, cash flow per share growth of +6.9%, and dividends growth of +7.4%, even though book value per share CAGR was -0.2%. Looking forward, estimated revenue per share rises from $66.01 in 2025 to $69.85 in 2026 and $74.65 in 2027. In a merely average industry ranking environment, that sort of company-specific improvement can be enough to create relative outperformance if execution stays intact. Said differently, RTX does not need a sector-wide rerating to generate catalysts; it mainly needs to keep posting disciplined, repeatable numbers.

My DCF starts from 2025 free cash flow of $7.94B, operating cash flow of $10.57B, and CapEx of $2.63B, all anchored to the authoritative spine. Because the explicit 2025 revenue line is missing, I infer a working 2025 revenue base from the spine’s 2024 revenue of $80.74B and +17.1% YoY revenue growth, which yields roughly $94.55B. I then project a five-year cash-flow path that grows 8%, 7%, 6%, 5%, and 4% respectively, reflecting continued aerospace and defense demand but a clear fade from the very strong 2025 growth rates. I use the spine’s WACC of 6.1%, a 3.0% terminal growth rate, and the economically valid 1.36B diluted shares rather than the clearly inconsistent 1.4M identity field.

On margin sustainability, RTX does have a meaningful position-based competitive advantage: installed fleet exposure, certification barriers, defense program entrenchment, and scale in aftermarket/service networks. Those attributes support maintaining approximately current profitability, so I do not force a sharp mean reversion from the spine’s 10.5% operating margin and 9.0% FCF margin. That said, returns are solid rather than extraordinary—ROIC is 7.7% and ROE is 10.3%—so I also do not underwrite aggressive structural margin expansion. The result is a balanced model: stable-to-slightly improving cash conversion, modest growth fade, and a fair value of about $198 per share. This framework is far more decision-useful than the raw deterministic DCF in the spine, which is distorted by the share-count mismatch visible in the FY2025 10-K data.

Using the authoritative stock price of $172.79 and the economically valid 1.36B diluted shares, RTX’s equity value is about $269.50B. Adding reported long-term debt of $41.08B and subtracting year-end cash of $7.43B gives an approximate enterprise value of $303.15B. Against 2025 free cash flow of $7.94B, the market is paying roughly 38x EV/FCF. In reverse DCF terms, that is not pricing collapse, but it is absolutely pricing durability: the current quote is consistent with about 4.6% annual FCF growth for a decade if one assumes the spine’s 6.1% WACC and a 3.0% terminal growth rate.

Those implied expectations are demanding but not absurd for a large aerospace and defense franchise with installed-base exposure, aftermarket economics, and entrenched defense programs. The issue is less whether RTX can grow at all and more whether it can keep cash conversion near the spine’s 9.0% FCF margin while preserving profitability around the current 10.5% operating margin. If management merely sustains 2025 performance, the stock looks approximately fairly valued. If it compounds meaningfully above that baseline, upside opens. If growth slips toward low single digits while the market insists on derating the current 40.0x P/E, the downside can show up quickly. In short, the market is already underwriting competence and moderate growth; it is not gifting a valuation cushion.

RTX’s SEC filings show a business that entered 2025 with solid top-line momentum and then converted that into meaningfully better earnings. In the 2024 revenue cadence disclosed through the 10-Qs and 10-K, revenue rose from $19.30B in Q1 2024 to $19.72B in Q2, $20.09B in Q3, and an implied $21.62B in Q4, reaching $80.74B for FY2024. That exit rate matters because it set up the stronger 2025 profit profile. In 2025, operating income moved from $2.04B in Q1 to $2.15B in Q2, $2.52B in Q3, and an implied $2.60B in Q4, producing $9.30B for the year and an exact computed 10.5% operating margin. Net income was $6.73B with an exact computed 7.6% net margin, while diluted EPS reached $4.96, up 39.7% year over year.

The quarter-by-quarter detail also shows why quality of the improvement matters. Net income increased from $1.53B to $1.66B to $1.92B through Q3 2025, but implied Q4 net income was $1.62B, below Q3 even as operating income improved. That pattern suggests taxes or other below-the-line items, not deterioration in operating execution. Compared with peers such as Boeing and General Electric, the data spine only supplies peer names and not audited peer margins, so exact numerical peer comparisons are . Still, RTX’s own numbers compare favorably to a stressed aerospace profile because it generated 41.0% net-income growth while preserving disciplined cost ratios.

• Positive: revenue momentum in 2024 translated into 2025 operating leverage.
• Positive: R&D stayed at 3.2% of revenue and SG&A at 6.9% of revenue, indicating margin expansion was not achieved by underinvesting.
• Watch item: implied Q4 2025 EPS of $1.19 trailed Q3’s $1.41, so the final quarter was not a clean straight-line acceleration.

Bottom line: the 10-Q and 10-K evidence supports a conclusion that RTX improved true operating profitability in 2025, but investors should separate core operating momentum from year-end non-operating volatility.

RTX ended 2025 with a balance sheet that looks stable rather than pristine. Per the SEC balance sheet, total assets were $171.08B, total liabilities were $103.94B, and shareholders’ equity was $65.25B at 2025-12-31. Current assets improved from $51.13B at 2024 year-end to $60.33B, while current liabilities rose from $51.50B to $58.78B, resulting in an exact computed current ratio of 1.03. That is enough to avoid a near-term liquidity alarm, but it is not enough to call the company overcapitalized. Cash and equivalents also improved from $5.58B to $7.43B, which is constructive and gives management more room to operate through normal aerospace working-capital volatility.

Leverage is meaningful but not acute. The exact computed debt-to-equity ratio is 0.63, total liabilities to equity is 1.59, and interest coverage is 5.0. Long-term debt declined from $43.64B in 2023 to $41.08B in 2024, which supports a deleveraging narrative, but the data spine does not provide total 2025 debt, short-term debt, or 2025 debt maturities, so gross debt, net debt, debt/EBITDA, and covenant headroom are . Quick ratio is also because inventory and receivables detail is not provided in the spine.

• Constructive: equity increased by $5.09B year over year, from $60.16B to $65.25B.
• Caution: goodwill was $53.34B, which is more than four-fifths of reported equity.
• Debt-service view: coverage of 5.0x is workable, but not loose enough to ignore execution risk.

The main balance-sheet issue is therefore not imminent distress; it is that liquidity is tight and book equity is heavily supported by acquired intangibles. That combination leaves RTX dependent on steady program execution and limits the margin for a major operating miss.

RTX’s 2025 cash flow profile is one of the strongest parts of the investment case. The data spine shows operating cash flow of $10.567B, capex of $2.63B, and exact computed free cash flow of $7.94B, equal to an exact computed 9.0% FCF margin. Most importantly, free cash flow was higher than annual net income of $6.73B. On a simple analytical basis derived from the authoritative figures, FCF conversion was approximately 118.0% of net income. For a large aerospace and defense industrial, that is a good quality signal because it suggests reported earnings are backed by real cash rather than being driven mainly by accruals.

Capex intensity looks manageable, but 2025 capex as a percentage of 2025 revenue is because annual 2025 revenue is not explicitly listed in the SEC line items. What is visible is that capex was essentially flat year over year at $2.62B in 2024 and $2.63B in 2025, while depreciation and amortization rose modestly from $4.36B in 2024 to $4.38B in 2025. That points to a business with good cash generation and no sign of capex stress. Working-capital intensity is still relevant, however, because year-end liquidity remained narrow with a 1.03 current ratio.

• Positive: OCF comfortably covered capex by roughly 4.0x on a simple analytical basis.
• Positive: FCF exceeded net income by about $1.21B.
• Watch item: cash conversion cycle is because inventory, receivables, and payables detail is not provided.

Based on the 10-K and 10-Q cash-flow evidence, RTX currently looks like a cash-generative industrial franchise with enough internal funding to support reinvestment and shareholder returns, provided working-capital discipline does not weaken.

The best-supported conclusion on capital allocation is that RTX is funding the business without starving it. SEC-reported R&D was $2.81B in 2025, equal to an exact computed 3.2% of revenue, while SG&A was $6.09B, or 6.9% of revenue. That mix suggests management maintained engineering and program support while still delivering a 10.5% operating margin and 7.94B of free cash flow. Capex was $2.63B, almost unchanged from $2.62B in 2024, which reads as steady reinvestment rather than abrupt expansion or retrenchment. The reported decline in long-term debt from $43.64B in 2023 to $41.08B in 2024 is also consistent with at least some deleveraging discipline before the stronger 2025 earnings year.

Where the audit trail gets thinner is shareholder distribution efficiency. The data spine does not provide buyback spend, average repurchase price, audited dividend cash outlay, or payout ratio, so whether buybacks were executed above or below intrinsic value is , and dividend payout ratio is also . M&A effectiveness is similarly hard to score quantitatively because the current evidence mainly shows the consequence of past deals in the form of $53.34B of goodwill, not a deal-by-deal return analysis. Against named peers such as Boeing and General Electric, exact R&D comparisons are because peer audited figures are not supplied in the spine.

• Supported positive: reinvestment was sustained, not cut, during a year of improving profitability.
• Supported positive: SBC was only 0.6% of revenue, so reported economics are not heavily distorted by equity compensation.
• Main caution: large goodwill means historical acquisition value remains a live balance-sheet quality question.

My read is that capital allocation has been reasonable on operating reinvestment and debt control, but the absence of audited buyback and dividend detail prevents a stronger conclusion on shareholder-return efficiency.

RTX’s 2025 cash deployment pattern reads as disciplined rather than aggressive. Based on the authoritative spine, the company generated $10.567B of operating cash flow and $7.94B of free cash flow after $2.63B of capex. That means roughly 33.1% of free cash flow was effectively absorbed by capital expenditures, while the business still had significant residual cash generation capacity. Using the institutional survey’s $2.67 dividend per share and the latest diluted share count of about 1.36B, estimated annual dividend cash usage is roughly $3.63B, or about 45.7% of 2025 free cash flow. That points to a dividend-first capital return framework, not a buyback-led one.

The remaining uses look split between balance-sheet support and retained flexibility. Cash and equivalents increased from $5.58B at 2024 year-end to $7.43B at 2025 year-end, a rise of $1.85B. Separately, long-term debt had already declined from $43.64B in 2023 to $41.08B in 2024, showing a willingness to de-risk rather than maximize distributions. R&D remained meaningful at $2.81B, or 3.2% of revenue, which is important because in aerospace/defense the best capital allocation is often sustained internal investment rather than headline buybacks.

Compared with peers such as Boeing and General Electric, the qualitative difference is that RTX currently looks more balanced between shareholder returns and balance-sheet resilience, though peer cash deployment percentages are in the supplied spine. The relevant SEC basis for this view is the company’s 2025 annual EDGAR filing data, which shows enough internally generated cash to fund reinvestment and dividends without signaling a need for financially engineered returns.

Using Greenwald’s framework, RTX’s market appears best classified as semi-contestable, not cleanly non-contestable and not fully contestable. The reason is that the business clearly operates behind meaningful barriers — scale, engineering depth, qualification requirements, and reputation matter — yet the available evidence does not show a single dominant incumbent that new or existing rivals cannot realistically challenge. RTX generated $80.74B of revenue in 2024 and spent $2.81B on R&D, $6.09B on SG&A, and $2.63B on CapEx in 2025. That cost structure is hard for a de novo entrant to replicate quickly.

The demand-side question is less conclusively answered. Could a rival offering a comparable product at the same price capture equivalent demand? The available spine suggests not immediately, because aerospace and defense purchases are experience-heavy, qualification-sensitive, and reputationally loaded, but the necessary proof points — market share by segment, customer concentration, backlog, aftermarket mix, and explicit switching-cost evidence — are missing. That means we cannot elevate RTX to a clearly non-contestable position.

Just as important, peer framing indicates that other large incumbents exist. Boeing and General Electric appear in the institutional peer set, implying RTX competes inside a field of already-scaled firms rather than defending a monopoly niche. In Greenwald terms, that shifts the analysis away from “what protects the only incumbent?” toward “how protected are multiple incumbents, and when do they cooperate versus compete?” This market is semi-contestable because barriers are high enough to deter fresh entrants, but multiple large incumbents likely share those protections, making strategic interaction and program-level rivalry central to profitability.

RTX clearly has meaningful economies of scale. A useful fixed-cost proxy from the spine is the combination of R&D ($2.81B), SG&A ($6.09B), and D&A ($4.38B), which totals roughly $13.28B. Against $80.74B of revenue, that is about 16.4% of sales represented by costs that are at least partly fixed or scale-sensitive. Adding $2.63B of CapEx highlights the capital commitment required to remain relevant. This is not a commodity shop that a new entrant can copy with a small balance sheet.

Minimum efficient scale is therefore likely meaningful. An entrant at only 10% of RTX’s revenue base would have about $8.07B of sales. If that entrant needed even half of RTX’s fixed-cost-like spending to field a remotely comparable engineering, program-management, and support footprint, it would carry about $6.64B of quasi-fixed cost against $8.07B of revenue — roughly 82.2% of sales versus RTX’s 16.4% proxy. That implies a massive cost handicap. Even if the entrant narrowed scope materially, the disadvantage would still be severe.

But Greenwald’s key point is that scale alone is not enough. If customers would switch freely at the same price, a large incumbent’s cost edge can eventually be matched by another scaled player. RTX’s scale advantage becomes durable only where it is paired with customer captivity through reputation, installed qualification, or service dependence. The spine strongly supports the cost-side moat; it only partially supports the demand-side moat. That is why RTX looks competitively advantaged, but not unambiguously invulnerable.

RTX does not read as a clean “N/A — already position-based” case. The better conclusion is that management appears to be operating from a capability- and resource-based base, while only partially converting that into position-based advantage. The evidence for capability is strong: the company is large at $80.74B revenue, profitable at a 10.5% operating margin, and still reinvesting meaningfully with $2.81B of R&D and $2.63B of CapEx. The earnings profile is also improving faster than the top line, with +41.0% net income growth on +17.1% revenue growth, which suggests learning, execution, or mix benefits.

The conversion question is whether these capabilities are turning into harder customer captivity. On scale, the answer is yes: RTX’s breadth, support infrastructure, and cash generation — $10.567B operating cash flow and $7.94B free cash flow — let it defend programs and absorb shocks. On captivity, the answer is only partial. There is likely progress through reputation, qualification history, and service relevance, but the spine does not provide verified data on share gains, contract duration, installed-base monetization, or measured switching costs.

That makes the timeline uneven. In niches with long qualification cycles and incumbent service relevance, conversion may already be well advanced. At the consolidated level, however, the moat remains vulnerable if knowledge is portable and customers rebid aggressively at program boundaries. The practical read is that RTX is partway through the conversion: scale and capabilities are evident today, while the durability of customer lock-in still needs proof from future disclosures on aftermarket mix, backlog, and share retention.

In this industry, pricing is unlikely to look like consumer-goods list-price moves. The more relevant Greenwald question is whether firms use bids, concessions, escalation terms, service bundles, and margin discipline as communication devices. Direct evidence of a public price leader is in the spine. That matters because contract markets are inherently less transparent than posted-price markets: rivals often observe outcomes with delay and only partially see the embedded economics.

That said, the structural patterns are still recognizable. A scaled incumbent like RTX, with $80.74B in revenue, $9.30B of operating income, and $7.94B of free cash flow, has the balance-sheet capacity to signal discipline by refusing uneconomic bids or, alternatively, to punish defection at strategically important program boundaries. Focal points in this type of market are less about headline price and more about accepted return thresholds, escalation clauses, risk-sharing terms, and acceptable aftermarket economics. When one player stretches for share, punishment likely comes not via an immediate blanket price cut, but through sharper bidding on the next visible campaign, package bundling, or willingness to absorb margin temporarily.

The path back to cooperation is therefore also different from the BP Australia or Philip Morris examples that Greenwald uses as archetypes. Here, “return to cooperation” would likely mean a reversion to disciplined bid/no-bid behavior, reduced concession intensity, and margin restoration across successive contract vintages rather than explicit posted-price increases. The absence of transparent, frequent pricing means tacit coordination is harder to monitor, which is why the market probably oscillates between calm discipline and episodic competitive flare-ups.

RTX’s competitive position is strongest where simple scale matters. The company produced $80.74B of revenue in 2024, and the quarterly path within that year improved from $19.30B in Q1 to $19.72B in Q2 and $20.09B in Q3. On the profit side, 2025 operating income improved from $2.04B in Q1 to $2.15B in Q2 and $2.52B in Q3, ending the year at $9.30B. That is not the profile of a company losing relevance rapidly.

The limitation is that market share itself is . The spine does not provide segment share, installed-base share, backlog share, or book-to-bill, so the most precise Greenwald statement is that RTX appears to be a top-tier incumbent with stable-to-improving economic position, not a verified share gainer. Revenue growth of +17.1% and net income growth of +41.0% support the inference that the company’s position is at least stable and probably strengthening operationally.

For investment purposes, that distinction matters. If share is actually rising, today’s valuation may be more defensible. If instead the earnings improvement reflects temporary mix, cost recovery, or execution rather than durable share gains, the market may be over-ascribing moat quality. My base view is that RTX’s market position is strong and presently stable-to-improving, but the absence of verified share data means the trend call should be treated as an inference rather than a settled fact.

The most important barrier is not any single item; it is the interaction between scale, reputation, qualification friction, and financial staying power. On the cost side, RTX’s investment burden is obvious: $2.81B of R&D, $2.63B of CapEx, and $6.09B of SG&A in 2025. As a shorthand, a would-be entrant likely needs at least a multibillion-dollar annual spend just to build a credible technical, manufacturing, and support footprint. A bare-minimum entry ticket using only R&D plus CapEx is already about $5.44B, before factoring overhead, customer support, or working capital. That is a serious barrier.

On the demand side, the barrier is less directly quantified but still likely meaningful. For mission-critical products, brand acts as reputation; buyers care about reliability, qualification history, and lifecycle support. The exact switching cost in months or dollars is , but it is unlikely to be trivial in a complex aerospace/defense context. Search costs also matter because evaluating alternatives is expensive and risky, especially for long-lived systems.

Greenwald’s critical question is whether an entrant matching RTX’s product at the same price would win the same demand. The answer appears to be no in many high-stakes applications, because equivalent trust and support capability are not instantly replicable. But it is also not an automatic no everywhere, because the spine lacks proof on share, contract duration, and aftermarket lock-in. So the barrier set is real, and the moat is strongest where customer captivity and scale reinforce each other; where captivity is weak, entry resistance falls sharply.

The cleanest bottom-up anchor is RTX's $80.74B of 2024 revenue, because the spine does not provide a segment bridge for engines, avionics, missiles, aftermarket, or geography. That means any true bottom-up TAM by product line is ; the best we can do is use revenue as the current served-market floor and then test it against the only explicit external proxy available.

That proxy is the $430.49B 2026 global manufacturing market, which the evidence set explicitly says is too broad to be treated as RTX's direct TAM. Rolling that market forward at the stated 9.62% CAGR yields $517.30B in 2028; against that benchmark, RTX's current revenue equals about 18.8% of the proxy market, while a simple 17.1% company-growth scenario would raise the implied 2028 revenue base to about $151.8B.

• Assumption 1: 2024 revenue is the best observable served-market floor.
• Assumption 2: The manufacturing proxy is an upper bound, not direct TAM.
• Assumption 3: No double counting across defense, commercial, and aftermarket.

On that basis, RTX looks like a large incumbent with meaningful runway, but the direct TAM is not decision-grade without product-level market data.

On the only explicit market proxy in the spine, RTX's current penetration is approximately 18.8% ($80.74B divided by $430.49B). That is already a meaningful share, which tells us the story is not about an under-monetized niche; it is about whether RTX can keep expanding within adjacent product and service buckets faster than the broader proxy market.

The runway case is supported by the company's own operating profile: +17.1% revenue growth, +41.0% net income growth, $7.94B of free cash flow, and $2.81B of R&D spend in 2025. If RTX were to compound revenue at 17.1% while the proxy market compounds at 9.62%, the implied 2028 revenue base would be about $151.8B, or roughly 29.3% of the 2028 proxy TAM.

• Runway signal: revenue growth is outpacing the proxy market CAGR.
• Saturation risk: if the real aerospace/defense SAM is much smaller than the manufacturing proxy, share gains could be overstated.

The key question is therefore not whether growth exists, but whether the accessible market is large enough to sustain this pace for several more years.

RTX’s reported financials show a technology platform with real scale behind it. For FY2025, the company generated $80.74B of revenue, $9.30B of operating income, and $6.73B of net income while spending $2.81B on R&D. The computed R&D intensity of 3.2% of revenue is not startup-like, but for a mature aerospace and defense manufacturer it is still a significant recurring commitment. The key takeaway is that engineering spending is being carried by a business that also produced a 10.5% operating margin and a 7.6% net margin, indicating that investment is occurring alongside earnings rather than instead of earnings.

The quarterly cadence also matters. R&D expense was $637.0M in the 2025 first quarter, $697.0M in the 2025 second quarter, and $684.0M in the 2025 third quarter, reaching $2.02B on a nine-month cumulative basis before ending the year at $2.81B. That pattern suggests a steady development spend rather than an erratic or distressed budget. In capital-intensive industries, consistency often matters more than a single peak year because product certification, integration, and sustainment programs require long-duration engineering support. On that measure, RTX’s reported run rate looks durable.

Peer references in the institutional survey include Boeing Co and General Elect…, which provides at least a directional competitive frame even though product-by-product comparisons are outside the verified data set. What is verified is that RTX entered 2026 with the financial capacity to keep funding its roadmap: operating cash flow was $10.57B, free cash flow was $7.94B, and cash and equivalents rose to $7.43B at 2025 year-end from $5.58B at 2024 year-end. That combination supports continued internal development, manufacturing improvement, and installed-base support. Specific product claims beyond this financial evidence remain.

For product and technology analysis, the most important question is often not whether a company spent on R&D in one year, but whether it can keep spending through cycles, certification timelines, and customer program ramps. RTX’s 2025 cash profile supports that continuity. Operating cash flow was $10.57B and free cash flow was $7.94B, while annual R&D expense was $2.81B and CapEx was $2.63B. In practical terms, internally generated cash covered both categories. That is a favorable signal because it means engineering and production investment did not obviously depend on extraordinary financing conditions.

Balance-sheet support also improved during 2025. Cash and equivalents increased from $5.58B at 2024 year-end to $7.43B at 2025 year-end, while shareholders’ equity rose from $60.16B to $65.25B. Total assets expanded from $162.86B to $171.08B over the same period. Those figures matter for technology execution because aerospace and defense programs are typically long-tail commitments involving development, qualification, factory readiness, aftermarket support, and working-capital swings. A business with improving cash, equity, and asset scale is usually better positioned to carry that burden.

There are also a few caution flags worth noting. Goodwill stood at $53.34B at 2025 year-end, a very large absolute number, and long-term debt was $41.08B at 2024 year-end, with debt-to-equity at 0.63 by the computed ratio set. That does not negate the innovation case, but it does mean investors should separate engineering capability from acquisition accounting and capital structure. The favorable read-through is that interest coverage was 5.0 and the company still delivered 10.5% operating margin, suggesting the financial model currently leaves room for technology spending. Product-specific superiority versus Boeing Co or General Elect… remains, but the financial capacity to keep investing is clearly verified.

The institutional survey provides a useful, though not exhaustive, external cross-check on RTX’s technology posture. It assigns the company a Financial Strength rating of A, a Safety Rank of 2, a Timeliness Rank of 2, and Price Stability of 90. Industry positioning is listed as Aerospace/Defense with an industry rank of 43 of 94. None of those measures directly proves technical leadership, but together they suggest the market and external evaluators see RTX as a comparatively resilient platform rather than a fragile turnaround. As of Mar 22, 2026, the stock price was $198.16, and the independent 3-5 year target price range was $185.00 to $250.00, implying the outside view is constructive but not euphoric.

The same survey lists peer companies including Boeing Co and General Elect…, which helps frame the competitive set around other large industrial and aerospace names. Historical per-share data also show steady progression: revenue per share moved from $60.61 in 2024 to $66.01 in 2025, while EPS moved from $5.73 to $6.28, and OCF per share increased from $9.06 to $9.62. Over four years, the institutional survey shows a 10.1% CAGR for EPS and 6.9% CAGR for cash flow per share. For technology investors, that pattern is relevant because it suggests engineering spending has been accompanied by improving monetization rather than stranded cost.

Still, there are limits to what can be claimed from the verified data. The spine does not provide product-level market shares, platform win rates, patent counts, or detailed customer awards, so any assertion that RTX has superior propulsion, avionics, sensors, or missile technology versus Boeing Co or General Elect… would be. What can be stated confidently is narrower but important: by FY2025, RTX had the earnings base, cash generation, and balance-sheet scale to sustain a multibillion-dollar technology agenda. In a sector where program cycles are long and reliability matters, that is itself a meaningful competitive attribute.

The most important concentration risk in this pane is that RTX does not disclose a supplier roster, a single-source percentage, or a customer concentration schedule Spine. That means the usual top-5/top-10 concentration test cannot be run, and the company’s exposure to a sole-source casting house, forging shop, electronics provider, or logistics lane remains rather than measured.

What we do know from the audited 2025 balance sheet is that RTX is not operating with a large liquidity buffer. Current assets were $60.33B versus current liabilities of $58.78B, leaving only a $1.55B working-capital cushion and a current ratio of 1.03. That matters because supply concentration is most dangerous when it collides with tight liquidity: a delayed shipment, accelerated freight bill, or supplier prepayment can force management to choose between protecting delivery schedules and protecting cash.

In other words, the risk here is not just whether concentration exists; it is whether concentration is hidden in a network that the market cannot see. RTX’s strong 2025 free cash flow of $7.94B helps, but it does not substitute for disclosed supplier diversification. Until the company publishes supplier or program-level exposure, the single-point-of-failure question remains open and should be treated as a valuation and execution risk, not a proven weakness.

The Data Spine does not provide a manufacturing map, sourcing-region split, or any single-country dependency percentage, so RTX’s geographic concentration risk cannot be quantified directly. That means we cannot say what share of inputs come from the U.S., Europe, Asia, or any other region, and we cannot measure tariff pass-through, export-control exposure, or port/logistics bottlenecks with precision.

Our provisional view is that the geographic risk score should be treated as 6/10 until the company discloses more detail. That is not a claim that RTX is overexposed to any one country; it is a reflection of the fact that a complex aerospace manufacturer can carry hidden risk in sub-tier castings, electronic controls, and specialty materials that are often sourced through multi-layer networks. The absence of disclosure is itself a risk factor because the market cannot separate diversified sourcing from concentrated sourcing.

On the mitigating side, RTX’s 2025 operating cash flow of $10.567B and free cash flow of $7.94B provide flexibility to absorb tariff friction, expedite freight, or dual-source a constrained part if needed. But without a sourcing-region schedule, this remains a cash-backed resilience argument rather than a verified geographic-risk analysis. If the next filing shows heavy single-country dependence in one or two sub-tiers, the risk score would need to move materially higher.

Our valuation outputs sit far outside the range implied by market trading and the independent institutional survey. The deterministic DCF produces a per-share fair value of $423,589.26, based on an enterprise value of $619.12B, equity value of $585.27B, 6.1% WACC, and 4.0% terminal growth. Scenario values remain exceptionally high across the range: $947,319.80 in the bull case, $423,589.26 in the base case, and $181,555.43 in the bear case. The Monte Carlo output points in the same direction, with a median value of $229,952.79, a mean of $302,255.67, a 5th percentile of $71,968.23, a 95th percentile of $815,629.11, and P(upside)=100.0% versus the current market price of $172.79 on Mar 22, 2026.

Those outputs should be interpreted alongside the company’s reported operating momentum rather than in isolation. RTX posted $80.74B of 2024 revenue, then delivered $9.30B of 2025 operating income and $6.73B of 2025 net income, with diluted EPS at $4.96. Deterministic ratios show +17.1% revenue growth year over year, +41.0% net income growth, and +39.7% EPS growth, plus a 10.5% operating margin, 7.6% net margin, and 9.0% free-cash-flow margin. In other words, the fundamentals are improving, but the sheer scale of the model-to-market dislocation is still extraordinary.

For street work, that means the more practical anchor is likely the independent survey rather than the raw model output alone. The same survey places RTX in Aerospace/Defense with an industry rank of 43 of 94, assigns a Safety Rank of 2, Timeliness Rank of 2, and Financial Strength of A, and lists peers including Boeing Co and General Electric. Specific peer valuation figures are , so the key takeaway is that external expectations appear constructive but bounded, while our quantitative model indicates a valuation disconnect that requires careful scrutiny before being treated as investable at face value.

The external expectation set embedded in the independent institutional survey is materially more conservative than our intrinsic value framework. At the share-price level, the survey’s $185.00 to $250.00 3-5 year target range brackets the current price of $198.16 as of Mar 22, 2026, implying that outside analysts see RTX as roughly fairly valued to moderately undervalued rather than massively mispriced. At the earnings level, the survey points to a $12.00 3-5 year EPS estimate. Nearer-term survey history shows EPS moving from $5.73 in 2024 to $6.28 in 2025, then to estimated EPS of $6.80 in 2026 and $7.50 in 2027. That cadence is constructive, but it still does not support the extreme spread between the market quotation and the DCF output.

The same pattern shows up in per-share operating metrics. Survey revenue per share rises from $60.61 in 2024 to $66.01 in 2025, then to $69.85 in 2026 and $74.65 in 2027. Operating cash flow per share improves from $9.06 in 2024 to $9.62 in 2025, with estimates of $10.10 in 2026 and $10.90 in 2027. Book value per share moves from $45.16 in 2024 to $48.61 in 2025, then $50.95 in 2026 and $53.40 in 2027. Dividends per share step from $2.48 in 2024 to $2.67 in 2025, $2.90 in 2026, and $3.05 in 2027. This is the profile of a steady compounder, not a consensus “explosive rerating” story.

That framing matters because the survey also paints RTX as relatively high quality and stable rather than highly speculative. The company carries Beta 1.00, Alpha 0.30, Price Stability 90, and Earnings Predictability 55. Peers named in the survey include Boeing Co and General Electric, but peer-specific target prices, margin comparisons, and trading multiples are in the provided evidence set. Bottom line: street-style expectations appear to center on continued earnings, cash-flow, dividend, and book-value progression, while our internal valuation outputs imply a much larger disconnect that should be cross-checked carefully against assumptions rather than accepted as consensus.

RTX does have balance-sheet exposure to rates, but the bigger macro issue is equity-duration sensitivity rather than an imminent funding problem. The hard numbers from the Data Spine show debt-to-equity of 0.63, interest coverage of 5.0, cash of $7.43B at 2025-12-31, and a current ratio of 1.03. That is consistent with a company that can absorb ordinary credit tightening, but not one that is fully insulated from a higher-for-longer rate regime. Long-term debt improved from $43.64B at 2023-12-31 to $41.08B at 2024-12-31, which modestly reduces refinancing pressure. The exact floating-versus-fixed debt mix in the 10-K/10-Q detail provided to the spine is , so direct cash-interest sensitivity cannot be reconstructed from the source package.

For valuation, RTX screens like a long-duration asset. Using the provided WACC of 6.1% and terminal growth of 4.0%, a simple perpetuity-style sensitivity implies an effective FCF duration of roughly 48-50 years. On that math, a +100 bp move in discount rate can reduce theoretical value by about 32%, while a -100 bp move could lift value by about 48%, before any change in fundamentals. That sensitivity is much larger than likely near-term interest expense drift. The deterministic DCF output in the model shows a per-share fair value of $423,589.26, with $947,319.80 bull and $181,555.43 bear, but those numbers are clearly distorted by the share-count inconsistency between 1.4M shares outstanding and 1.36B diluted shares. In practical portfolio terms, the 10-K/10-Q data say RTX is not a balance-sheet casualty of high rates, yet the stock is still vulnerable if rate pressure lifts the equity risk premium above the current 5.5% assumption.

• EDGAR-backed resilience: $7.94B free cash flow and $10.567B operating cash flow in 2025.
• Key missing item: debt maturity ladder and fixed/floating mix are in the spine.
• Portfolio implication: treat RTX as moderately credit-sensitive but meaningfully duration-sensitive.

The provided filings and computed ratios make one point very clear: RTX has enough fixed-cost structure that input inflation can flow through to margin volatility, even if the exact commodity basket is not disclosed in the spine. In 2025, RTX reported $2.81B of R&D expense, equal to 3.2% of revenue, and $6.09B of SG&A, equal to 6.9% of revenue. Combined with a 10.5% operating margin and 9.0% free-cash-flow margin, that suggests the company has some room to absorb raw-material pressure, but not infinite room if inflation persists while pricing lags. The exact percentage of COGS tied to titanium, nickel, aluminum, composites, energetics, electronics, or rare-earth-related components is in the Data Spine, and so is any formal hedging program.

For macro analysis, the right framing is scenario-based rather than declarative. If input costs rise and RTX cannot reprice quickly, margin compression should be expected because expense flexibility is imperfect. The company’s 2025 operating-income progression from $2.04B in Q1 to an implied $2.60B in Q4 shows positive operating leverage in a supportive environment; the reverse would likely occur if commodity inflation hit procurement before contract repricing. My working assumption is that a broad commodity shock would be manageable rather than thesis-breaking because free cash flow of $7.94B provides buffer, but historical margin impact from prior commodity spikes is in the source set.

• EDGAR support: cost structure has meaningful semi-fixed components.
• Unknowns: exact commodities, a portion of COGS, pass-through clauses, and hedge coverage are .
• Implication: commodity inflation is more likely a margin-timing issue than a solvency issue.

Trade-policy risk should be treated as a second-order but non-zero macro variable for RTX. The Data Spine confirms a large industrial balance sheet, with $171.08B of total assets, $103.94B of total liabilities, and $53.34B of goodwill at 2025-12-31, but it does not disclose supplier-country concentration, China dependency, or tariff-exposed bill-of-material share. That means the precise percentage of procurement tied to China or other tariff-sensitive jurisdictions is . Because the company operates in aircraft engines and engine parts, a tariff shock would likely show up first through supplier-cost inflation, lead-time friction, and working-capital drag rather than through immediate demand destruction, but the exact channel cannot be quantified from the filings included here.

My analytical view is that tariff risk is manageable because RTX is entering 2026 from a position of earnings strength, not weakness. The company generated $6.73B of net income in 2025, $10.567B of operating cash flow, and $7.43B of cash, while long-term debt had already declined to $41.08B in the latest annual debt datapoint. On a scenario basis, if tariff-driven supply inflation hit a narrow portion of procurement and only part of that could be passed through, the margin hit would most likely be measured in basis points rather than in percentage points. The real risk is not a single tariff event; it is repeated trade friction that slows deliveries, raises inventory needs, and pressures the already tight 1.03 current ratio. Without a supplier geography schedule from the 10-K package in the spine, the actual China dependency percentage remains .

• Supportive facts: strong cash generation and moderate leverage reduce shock risk.
• Missing facts: tariff exposure by product line, China sourcing %, and contractual pass-through clauses are .
• Bottom line: trade policy is a margin nuisance unless it becomes a sustained supply-chain disruption.

The Data Spine does not provide a statistical correlation between RTX revenue and consumer confidence, GDP growth, housing starts, airline traffic, or defense budgets, so any direct macro-factor regression is . Still, the company-level data are enough to estimate operating elasticity. Revenue growth is reported at +17.1% YoY, while net income grew +41.0% and diluted EPS grew +39.7%. That implies EPS has recently moved at roughly 2.3x the pace of revenue growth. In practical terms, if top-line growth decelerates meaningfully because the macro cycle weakens, RTX’s earnings growth is likely to slow disproportionately; the same is true on the upside if production and demand remain firm.

The quarterly pattern reinforces that view. 2024 revenue climbed from $19.30B in Q1 to an implied $21.62B in Q4, and 2025 operating income rose from $2.04B in Q1 to an implied $2.60B in Q4. That is classic operating leverage. Because RTX sits in aerospace/defense rather than in a short-cycle retail category, I would not anchor demand sensitivity to consumer confidence alone; I would anchor it to broad industrial production, airline capex, defense procurement cadence, and credit conditions, all of which are in the Macro Context table. The actionable conclusion is that RTX is not highly exposed to the household cycle, but it is exposed to the business-investment and government-spending cycle through earnings conversion.

• Quantified elasticity: EPS growth +39.7% versus revenue growth +17.1%.
• Implication: a 1% revenue shock can plausibly drive a greater-than-1% earnings shock.
• Unknowns: direct correlation coefficients versus GDP, ISM, airline traffic, or confidence data are .

Using Buffett’s framework, RTX is a good business at a not-obviously-cheap price. On understandable business, I score it 4/5. The consolidated model is understandable at a high level: a large aerospace and defense platform with recurring aftermarket, OE exposure, and government-linked demand characteristics. The audited spine shows $80.74B of revenue in 2024 and improving 2025 profitability, which supports the idea that the operating model is economically legible even though segment detail is missing from this pane.

On favorable long-term prospects, I assign 4/5. The evidence is the 2025 run-rate: $9.30B of operating income, $6.73B of net income, $10.567B of operating cash flow, and $7.94B of free cash flow. Those figures imply real franchise durability. The institutional cross-check also shows Financial Strength A, Safety Rank 2, and forward EPS estimates of $6.80 for 2026 and $7.50 for 2027, which is supportive of continued compounding.

On able and trustworthy management, I score 3/5. The case for competence is improving quarterly execution in the 2025 10-Q pattern: operating income rose from $2.04B in Q1 to $2.15B in Q2 and $2.52B in Q3, while CapEx stayed disciplined at $2.63B for the year, essentially flat with $2.62B in 2024. However, this pane does not have DEF 14A compensation details or Form 4 insider activity, so I cannot push the score higher without marking those areas .

On sensible price, RTX gets only 2/5. At a live price of $198.16 and a deterministic 40.0x P/E, investors are paying up for resilience and continued repair. My overall Buffett checklist score is therefore 13/20, equivalent to a B-: the business quality is attractive, but the price only works if the earnings trajectory keeps improving.

• Strength: free cash flow of $7.94B and FCF margin of 9.0%.
• Supportive: ROE 10.3%, ROIC 7.7%, Financial Strength A.
• Limitation: goodwill of $53.34B versus equity of $65.25B reduces balance-sheet purity.
• Valuation friction: P/E of 40.0 is far above classic value thresholds.

I score RTX at 6/10 conviction. The weighting matters more than the headline. My first pillar is Earnings and cash-flow durability, weighted 35% and scored 8/10. The evidence quality is High because it comes directly from the audited 2025 operating and cash-flow data: $9.30B operating income, $6.73B net income, $10.567B operating cash flow, and $7.94B free cash flow. That is the strongest part of the case.

The second pillar is Balance-sheet resilience, weighted 20% and scored 5/10, evidence quality High. Debt to equity of 0.63 and interest coverage of 5.0 are manageable, but a current ratio of 1.03 is only barely comfortable and goodwill of $53.34B versus equity of $65.25B reduces downside asset support. This is not a distressed balance sheet, but it is not fortress-like either.

The third pillar is Valuation attractiveness, weighted 25% and scored 4/10, evidence quality Medium. The stock trades at $198.16 and 40.0x earnings. My corrected weighted fair value is only $211.25, with bull/base/bear cases of $250, $215, and $165. That does not create enough upside to support a high-conviction value call today.

The fourth pillar is Data integrity and underwrite-ability, weighted 20% and scored 6/10, evidence quality Medium. The reason this is not lower is that the core operating facts are clean. The reason it is not higher is the share-count mismatch, which likely contaminates the deterministic DCF and Monte Carlo outputs. The weighted total is:

• Durability: 8 x 35% = 2.80
• Balance sheet: 5 x 20% = 1.00
• Valuation: 4 x 25% = 1.00
• Data integrity: 6 x 20% = 1.20
• Total: 6.00 / 10

The contrarian bear case is valid: if the market stops paying 40x for mid-teens revenue growth and 10.5% operating margins, the stock could de-rate even while the company remains fundamentally sound.

RTX’s current accounting profile looks broadly credible on the numbers provided, mainly because reported earnings are accompanied by meaningful cash generation rather than being driven only by accruals. For full-year 2025, net income was $6.73B, while operating cash flow was $10.57B and free cash flow was $7.94B. That relationship is important in any governance review because it suggests earnings were backed by cash realization. The company also reported operating income of $9.30B on $80.74B of revenue, which corresponds to a deterministic operating margin of 10.5%, while net margin was 7.6%. Diluted EPS was $4.96 for 2025, with EPS growth of +39.7% year over year and net income growth of +41.0%.

Expense structure also looks transparent enough to analyze. RTX reported 2025 R&D expense of $2.81B, equal to 3.2% of revenue, and SG&A of $6.09B, equal to 6.9% of revenue. Those are useful anchors because they show the company is not reporting earnings growth simply by starving investment lines. Capital intensity also appears steady rather than erratic: capex was $2.63B in 2025, very close to $2.62B in 2024, while depreciation and amortization was $4.38B in 2025 and $4.36B in 2024.

From a governance lens, the quality signal is therefore mixed but acceptable: cash conversion and earnings growth are constructive, yet investors should not ignore the large balance-sheet intangible load and leverage. Relative to peers named in the independent survey, including Boeing Co and General Electric, RTX’s reported figures point to steadier profitability and a less obviously distressed financial profile, although this pane cannot verify peer financial magnitudes from the spine and any direct peer numeric comparison is therefore.

The main governance question on RTX’s balance sheet is not near-term solvency so much as composition. Total assets increased from $162.86B at 2024 year-end to $171.08B at 2025 year-end. Over the same period, total liabilities moved from $100.90B to $103.94B and shareholders’ equity rose from $60.16B to $65.25B. That direction is constructive because equity expanded alongside asset growth, rather than being eroded. Cash and equivalents also improved from $5.58B at 2024 year-end to $7.43B at 2025 year-end, which provides a better liquidity cushion. Current assets reached $60.33B and current liabilities were $58.78B at the end of 2025, consistent with the reported current ratio of 1.03.

The more important balance-sheet governance watch item is goodwill. RTX reported goodwill of $52.79B at 2024 year-end and $53.34B at 2025 year-end. In absolute terms that is a very large figure relative to the company’s $65.25B of year-end equity. Large goodwill balances do not automatically imply poor accounting quality, but they do raise the stakes for management judgment around acquisition assumptions, segment performance, discount rates, and impairment testing. Investors should therefore treat any future deterioration in end-market conditions, margins, or capital allocation as especially relevant to accounting quality because those factors can eventually affect carrying values.

Leverage appears manageable rather than trivial. Long-term debt was $41.08B at 2024 year-end, and the deterministic debt-to-equity ratio is 0.63. Total liabilities to equity stands at 1.59, while interest coverage is 5.0. Taken together, those figures do not point to immediate balance-sheet distress, but they do argue for continued discipline. Compared with institutional survey peers such as Boeing Co and General Electric, RTX appears positioned as a financially stronger operator on the available rankings, though any exact peer leverage comparison is because those peer figures are not included in the spine.

RTX’s 2025 income and cash flow data support a relatively favorable earnings-quality reading. Reported net income was $6.73B, while operating cash flow was $10.57B and free cash flow was $7.94B. That spread matters because it indicates the company converted accounting earnings into cash at a healthy level during the year. Capex was $2.63B in 2025, almost unchanged from $2.62B in 2024, which suggests management did not manufacture free cash flow simply by sharply reducing investment. Depreciation and amortization was $4.38B in 2025 versus $4.36B in 2024, another sign of continuity rather than abrupt accounting swings.

The growth profile is also supportive. Revenue growth was +17.1% year over year, net income growth was +41.0%, and diluted EPS growth was +39.7%. Diluted EPS for 2025 was $4.96. While margin expansion alone can sometimes raise questions if it comes from unusually low spending, RTX still reported R&D expense of $2.81B and SG&A of $6.09B in 2025. On a ratio basis, R&D was 3.2% of revenue and SG&A was 6.9% of revenue. Those levels imply the company continued to fund engineering and overhead requirements while growing profits.

There are still governance questions worth monitoring. A company generating $80.74B of annual revenue and operating in aerospace/defense can produce quarter-to-quarter timing effects around programs, collections, and costs, so a single year should not be treated as definitive. Even so, the current set of indicators does not show obvious signs of weak earnings quality. Relative to Boeing Co and General Electric, which are listed as peer references in the institutional survey, RTX’s independent rankings of Safety 2, Timeliness 2, and Financial Strength A reinforce a view that accounting outcomes are presently aligned with fundamental operating performance rather than detached from it.

If an investor is trying to decide whether RTX deserves a governance premium, the most persuasive positive points in the data are consistency, scale, and cash support. The company ended 2025 with $171.08B of assets, $65.25B of equity, $7.43B of cash, and $6.73B of net income. Operating cash flow of $10.57B and free cash flow of $7.94B provide further support for the view that reported profits are not merely optical. The company’s computed return metrics are respectable rather than spectacular, with ROE at 10.3%, ROA at 3.9%, and ROIC at 7.7%. Those are not numbers that suggest a broken business model or a governance regime leaning on excessive accounting complexity to hide weak economics.

What still deserves close supervision is the interaction of leverage and intangible assets. Total liabilities were $103.94B at 2025 year-end, total liabilities to equity was 1.59, and goodwill was $53.34B. In practice, that means a meaningful portion of reported asset value depends on prior transaction pricing and management judgment. If future performance underwhelms, impairment risk could become more relevant. Liquidity is acceptable but tight enough to matter operationally, with current assets of $60.33B against current liabilities of $58.78B and a current ratio of 1.03.

On balance, the current evidence supports a view of RTX as a company with decent accounting quality and no obvious red flags in the audited financial spine, but not a company where governance analysis should be perfunctory. Investors comparing RTX with Boeing Co or General Electric should likely focus less on headline scale and more on the durability of cash generation, treatment of acquired intangibles, and whether future growth continues to convert into operating cash flow and free cash flow at levels similar to 2025. That is where governance quality will show up most clearly in the next reporting cycle.